Literature DB >> 19210032

Cognitive control in adolescents with neurofibromatosis type 1.

I Rowbotham1, I M Pit-ten Cate, E J S Sonuga-Barke, S C J Huijbregts.   

Abstract

Neurofibromatosis Type 1 (NF1) is a genetic disorder characterized by partial loss of growth control that affects the central nervous system. NF1 has been consistently associated with cognitive dysfunction, although there is no consensus on the cognitive profile in NF1 or on brain-cognition relationships. To clarify the pattern of cognitive dysfunction, performance of 16 NF1 patients and 16 age- and sex-matched controls (mean age = 14.5 years, SD = 1.3) was compared on computerized tasks measuring perception, executive functioning (inhibitory control, cognitive flexibility, and working memory), and motor control. A further aim of this study was to contrast performance on tasks or task parts requiring varying levels of cognitive control to find out whether this could explain potential difficulties experienced by this population in different cognitive domains or at different stages of information processing. Repeated measures analyses of variance showed that group differences, indicating poorer performance of NF1 patients, varied as a function of the level of cognitive control required. Evidence was also found for more basic motor skill problems in NF1 patients. Furthermore, NF1 patients were generally slower than controls. Results are discussed in the context of what is known about brain-cognition relationships in NF1. (c) 2009 APA, all rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19210032     DOI: 10.1037/a0013927

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  31 in total

Review 1.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 2.  Understanding intellectual disability through RASopathies.

Authors:  Alvaro San Martín; Mario Rafael Pagani
Journal:  J Physiol Paris       Date:  2014-05-21

3.  Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials.

Authors:  Jonathan M Payne; Belinda Barton; E Arthur Shores; Kathryn N North
Journal:  J Neurol       Date:  2012-08-09       Impact factor: 4.849

4.  Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.

Authors:  Carrie Shilyansky; Katherine H Karlsgodt; Damian M Cummings; Kyriaki Sidiropoulou; Molly Hardt; Alex S James; Dan Ehninger; Carrie E Bearden; Panayiota Poirazi; J David Jentsch; Tyrone D Cannon; Michael S Levine; Alcino J Silva
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

5.  Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors.

Authors:  Lauren S Krivitzky; Karin S Walsh; Evelyn L Fisher; Madison M Berl
Journal:  Child Neuropsychol       Date:  2015-07-06       Impact factor: 2.500

6.  Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.

Authors:  Maria J Ribeiro; Inês R Violante; Inês Bernardino; Richard A E Edden; Miguel Castelo-Branco
Journal:  Cortex       Date:  2014-11-11       Impact factor: 4.027

7.  Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.

Authors:  Marisa Loitfelder; Stephan C J Huijbregts; Ilya Milos Veer; Hanna S Swaab; Mark A Van Buchem; Reinhold Schmidt; Serge A Rombouts
Journal:  Brain Connect       Date:  2015-03-31

8.  Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network.

Authors:  Inês R Violante; Maria J Ribeiro; Gil Cunha; Inês Bernardino; João V Duarte; Fabiana Ramos; Jorge Saraiva; Eduardo Silva; Miguel Castelo-Branco
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Alterations in white matter microstructure in neurofibromatosis-1.

Authors:  Katherine H Karlsgodt; Tena Rosser; Evan S Lutkenhoff; Tyrone D Cannon; Alcino Silva; Carrie E Bearden
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukemia: a MEG study of power spectrum and correlated cognitive dysfunction.

Authors:  Marita Daams; Ilse Schuitema; Bob W van Dijk; Eline van Dulmen-den Broeder; Anjo Jp Veerman; Cor van den Bos; Leo Mj de Sonneville
Journal:  BMC Neurol       Date:  2012-08-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.